1. Home
  2. LGVN vs LITB Comparison

LGVN vs LITB Comparison

Compare LGVN & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • LITB
  • Stock Information
  • Founded
  • LGVN 2014
  • LITB 2007
  • Country
  • LGVN United States
  • LITB Singapore
  • Employees
  • LGVN N/A
  • LITB N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • LITB Catalog/Specialty Distribution
  • Sector
  • LGVN Health Care
  • LITB Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • LITB Nasdaq
  • Market Cap
  • LGVN 23.4M
  • LITB 20.5M
  • IPO Year
  • LGVN 2021
  • LITB N/A
  • Fundamental
  • Price
  • LGVN $1.31
  • LITB N/A
  • Analyst Decision
  • LGVN Strong Buy
  • LITB
  • Analyst Count
  • LGVN 3
  • LITB 0
  • Target Price
  • LGVN $8.67
  • LITB N/A
  • AVG Volume (30 Days)
  • LGVN 134.8K
  • LITB 10.4K
  • Earning Date
  • LGVN 08-13-2025
  • LITB 08-01-2025
  • Dividend Yield
  • LGVN N/A
  • LITB N/A
  • EPS Growth
  • LGVN N/A
  • LITB N/A
  • EPS
  • LGVN N/A
  • LITB 0.08
  • Revenue
  • LGVN $2,225,000.00
  • LITB $231,136,000.00
  • Revenue This Year
  • LGVN N/A
  • LITB N/A
  • Revenue Next Year
  • LGVN $51.48
  • LITB N/A
  • P/E Ratio
  • LGVN N/A
  • LITB $15.41
  • Revenue Growth
  • LGVN 127.50
  • LITB N/A
  • 52 Week Low
  • LGVN $1.14
  • LITB $0.91
  • 52 Week High
  • LGVN $6.40
  • LITB $5.70
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 51.52
  • LITB 51.05
  • Support Level
  • LGVN $1.27
  • LITB $1.11
  • Resistance Level
  • LGVN $1.40
  • LITB $1.25
  • Average True Range (ATR)
  • LGVN 0.09
  • LITB 0.09
  • MACD
  • LGVN 0.01
  • LITB 0.01
  • Stochastic Oscillator
  • LGVN 50.00
  • LITB 60.00

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: